Production of enantiomerically enriched chiral carbinols using Weissella paramesenteroides as a novel whole cell biocatalyst
Özet
In this study, four bacterial strains were tested for their ability to reduce acetophenones to its corresponding alcohol. Among these strains Weissella paramesenteroides N7 was found to be the most successful biocatalyst to reduce the ketones to the corresponding alcohols. The reaction conditions were systematically optimized for W. paramesenteroides N7 that resulted in high enantioselectivity and conversion rates for the bioreduction. The scale-up asymmetric reduction of 1-(4-methoxyphenyl) propan-1-one (1r) by W. paramesenteroides N7 gave (R)-1-(4-methoxyphenyl) propan-1-ol (2r) with 94% yield and >99% enantiomeric excess. This is the first report showing the synthesis of (R)-1-(4-methoxyphenyl) propan-1-ol (2r) in enantiopure form using a biocatalyst on a gram scale. The whole cell catalyzed the reductions of ketone substrates on the preparative scale, demonstrating that W. paramesenteroides N7 would be a valuable biocatalyst for the preparation of chiral aromatic alcohols of pharmaceutical interest as a promising and alternative green approach.
Anahtar Kelimeler
- Scopus
- 12
- WoS
- 10
- OpenAlex
- 11
Tam Kayıt
| Alan | Değer | Dil |
|---|---|---|
| dc.contributor.author | Tozlu, Caner | |
| dc.contributor.author | Şahin, Engin | |
| dc.contributor.author | Serencam, Hüseyin | |
| dc.contributor.author | Dertli, Enes | |
| dc.date.accessioned | 2026-10-29T19:09:16.629579436Z | |
| dc.date.available | 2026-10-29T19:09:16.629579436Z | |
| dc.date.issued | 2019 | |
| dc.description.abstract | In this study, four bacterial strains were tested for their ability to reduce acetophenones to its corresponding alcohol. Among these strains Weissella paramesenteroides N7 was found to be the most successful biocatalyst to reduce the ketones to the corresponding alcohols. The reaction conditions were systematically optimized for W. paramesenteroides N7 that resulted in high enantioselectivity and conversion rates for the bioreduction. The scale-up asymmetric reduction of 1-(4-methoxyphenyl) propan-1-one (1r) by W. paramesenteroides N7 gave (R)-1-(4-methoxyphenyl) propan-1-ol (2r) with 94% yield and >99% enantiomeric excess. This is the first report showing the synthesis of (R)-1-(4-methoxyphenyl) propan-1-ol (2r) in enantiopure form using a biocatalyst on a gram scale. The whole cell catalyzed the reductions of ketone substrates on the preparative scale, demonstrating that W. paramesenteroides N7 would be a valuable biocatalyst for the preparation of chiral aromatic alcohols of pharmaceutical interest as a promising and alternative green approach. | |
| dc.identifier.doi | 10.1080/10242422.2019.1568416 | |
| dc.identifier.eissn | 1029-2446 | |
| dc.identifier.endpage | 398 | |
| dc.identifier.issn | 1024-2422 | |
| dc.identifier.issue | 5 | |
| dc.identifier.scopus | 2-s2.0-85061243370 | |
| dc.identifier.startpage | 388 | |
| dc.identifier.uri | https://rdlopen.rawdatalibrary.net/r/bayburt/12177 | |
| dc.identifier.volume | 37 | |
| dc.identifier.wos | WOS:000477723200008 | |
| dc.language.iso | en | |
| dc.publisher | Taylor and Francis Ltd | |
| dc.relation.ispartof | Biocatalysis and Biotransformation | |
| dc.rights | info:eu-repo/semantics/closedAccess | |
| dc.subject | asymmetric synthesis | |
| dc.subject | Biotransformation | |
| dc.subject | chiral carbinols | |
| dc.subject | drug precursor | |
| dc.subject | enantioselective bioreduction | |
| dc.subject.classification | Biochemistry & Molecular Biology | |
| dc.subject.classification | Biotechnology & Applied Microbiology | |
| dc.subject.other | Enantiomers | |
| dc.subject.other | Enantioselectivity | |
| dc.subject.other | Ketones | |
| dc.subject.other | Methanol | |
| dc.subject.other | Reaction rates | |
| dc.subject.other | acetophenone | |
| dc.subject.other | acetophenone derivative | |
| dc.subject.other | Asymmetric synthesis | |
| dc.subject.other | Bio reductions | |
| dc.subject.other | Biotransformation | |
| dc.subject.other | chiral carbinols | |
| dc.subject.other | drug precursor | |
| dc.subject.other | Article | |
| dc.subject.other | bacterial cell | |
| dc.subject.other | bacterial strain | |
| dc.subject.other | biocatalyst | |
| dc.subject.other | biotechnological production | |
| dc.subject.other | chirality | |
| dc.subject.other | controlled study | |
| dc.subject.other | enantiomer | |
| dc.subject.other | enzyme active site | |
| dc.subject.other | high performance liquid chromatography | |
| dc.subject.other | incubation time | |
| dc.subject.other | nonhuman | |
| dc.subject.other | optical rotation | |
| dc.subject.other | pH | |
| dc.subject.other | reaction time | |
| dc.subject.other | reduction (chemistry) | |
| dc.subject.other | scale up | |
| dc.subject.other | substrate concentration | |
| dc.subject.other | temperature | |
| dc.subject.other | thin layer chromatography | |
| dc.subject.other | Weissella | |
| dc.subject.other | Weissella paramesenteroides | |
| dc.subject.other | whole cell | |
| dc.subject.other | Biocatalysts | |
| dc.title | Production of enantiomerically enriched chiral carbinols using Weissella paramesenteroides as a novel whole cell biocatalyst | |
| dc.type | Article | |
| rdl.citation.openalex | 11 | |
| rdl.citation.scopus | 12 | |
| rdl.citation.wos | 10 | |
| rdl.oa.status | closed | |
| rdl.scopus.quartile | Q3 | |
| rdl.source.index | SCOPUS | |
| rdl.source.index | WOS | |
| rdl.wos.index | Science Citation Index Expanded (SCI-EXPANDED) |
